ArticleBlood advances2025

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL.

Malte Roerden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.